你即將離開本站

並前往https://www.swissmedic.ch/dam/swissmedic/de/dokumente/marktueberwachung/rmp/adalimumab_hyrimoz-rmp-summary.pdf.download.pdf/Adalimumab_Hyrimoz_RMP-Summary.pdf

adalimumab (Hyrimoz®) RMP Summary - Swissmedic

Humira SmPC and are therefore considered as an important identified risk of Hyrimoz. Risk factors and risk.

確定！ 回上一頁

查詢 「Humira smpc」的人也找了：

  1. Humira smpc
    2.
  2. infliximab smpc
    3.
  3. enbrel smpc
    4.
  4. Humira indication approval timeline
    5.
  5. secukinumab smpc
    6.
  6. golimumab smpc
    7.
  7. amgevita smpc
    8.
  8. humira 20 mg pen
    9.